Established in April 2017, EverestIMS Technologies is an enterprise software provider delivering IT management solutions across both Software-as-a-Service (SaaS) models and on-premises environments. The company leverages artificial intelligence and digital technologies to streamline enterprise IT systems, optimize operational efficiency, and elevate user experience. Central to its offerings is the proprietary "Infraon Infinity" platform, engineered to oversee and monitor critical network infrastructure, enterprise servers, and applications, thereby reducing operational downtime and bolstering system performance.
Market Dashboard
EverestIMS Technologies
ListedSMEBook build Issue
Issue Price
₹80 to ₹85Face Value
₹10 Per Equity ShareIssue Size
Approx ₹48.46 CroresListing On
BSENSE
Live
Allotment Available
Check your individual allotment on the official registrar portal.
Grey Market
₹40
+47.06% Est. Listing Premium
Est. Listing Price₹125
Updated: 03 Oct 2026, 10:37
About EverestIMS Technologies IPO
Financial Health
Live Subscriptions
Tracking
Frequently Asked Questions
The public subscription window officially opens on 29 September 2026 and concludes at 5:00 PM IST on 05 October 2026.
As of the latest market information, the GMP is ₹40, indicating a 47.06% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹80 to ₹85. Retail investors must bid for at least 3200 shares, requiring a block investment of ₹2,72,000.
The allotment has been detected as available in the Maashitla Securities Pvt. Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 08 October 2026.
The registrar for this IPO is Maashitla Securities Pvt. Ltd..
The issue size for EverestIMS Technologies is Approx ₹48.46 Crores.
The current status of the EverestIMS Technologies IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.